Here’s How To Delete Your Personal Data And Genetic Sample From 23andMe

23andMe customers who once turned over the most personal form of information to the company — their own genetic data — may want it back after the personal genomics and biotech startup declared bankruptcy on Sunday.

The 19-year-old company is seeking a buyer, which means that if it is not deleted, customer data could be transferred to any company that acquires 23andMe.

California-based 23andMe has more than 15 million customers worldwide for whom it provides information on genetic ancestry and health. The company also has a therapeutics arm, which conducts research and works to develop treatments for a range of conditions and diseases.

Even before 23andMe had sought bankruptcy protection, California Attorney General Rob Bonta on Friday urged customers to immediately delete “the trove of sensitive consumer data” the company has collected, including samples of people’s genetic material.

How do I delete my 23andMe data?

23andMe states that if it’s involved in a bankruptcy or sale, customers’ personal data may also be sold or transferred. It also provides a relatively straightforward way for customers to delete their data and request that their genetic samples be destroyed.

“If, at any time, you are no longer interested in participating in our Services, you may delete your 23andMe account directly within your Account Settings,” the company states on its website.

That requires you to log in to your account and submit a request. The company will then send an an email asking users to confirm the deletion request. You must reply in the affirmative for the deletion process to be completed.

How to delete your 23andMe data

  1. Log in to your account
  2. Go to “settings”
  3. Scroll to “23andMe data”
  4. Click “view”
  5. Scroll to “delete data”
  6. Click “permanently delete data”
  7. Confirm your request

Note that you may also download a copy of your genetic data before deleting it from 23andMe’s database.

How to delete your 23andMe test sample

  1. Log in to your account
  2. Go to “settings”
  3. Go to “preferences”

Users can also opt to let the company share their personal data. Currently, a handful of states have passed privacy laws that would require customers’ consent before their genetic data is transferred. Customers can withdraw such permission under “Research and Product Consents” on the account settings page.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square